Brokerages forecast that NextGen Healthcare, Inc. (NASDAQ:NXGN) will post $0.24 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have made estimates for NextGen Healthcare’s earnings, with the lowest EPS estimate coming in at $0.21 and the highest estimate coming in at $0.28. NextGen Healthcare reported earnings of $0.30 per share during the same quarter last year, which would suggest a negative year over year growth rate of 20%. The business is expected to announce its next quarterly earnings results on Thursday, October 28th.
On average, analysts expect that NextGen Healthcare will report full-year earnings of $0.93 per share for the current fiscal year, with EPS estimates ranging from $0.91 to $0.94. For the next year, analysts expect that the business will report earnings of $0.99 per share, with EPS estimates ranging from $0.94 to $1.04. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover NextGen Healthcare.
NextGen Healthcare (NASDAQ:NXGN) last released its earnings results on Thursday, July 29th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.11. NextGen Healthcare had a net margin of 2.31% and a return on equity of 12.73%. The business had revenue of $146.08 million during the quarter, compared to the consensus estimate of $139.97 million.
In related news, Director Craig A. Barbarosh sold 9,000 shares of the stock in a transaction that occurred on Tuesday, August 3rd. The stock was sold at an average price of $16.14, for a total transaction of $145,260.00. Following the completion of the transaction, the director now directly owns 72,946 shares of the company’s stock, valued at $1,177,348.44. The sale was disclosed in a filing with the SEC, which is available through this link. 18.50% of the stock is currently owned by corporate insiders.
Large investors have recently bought and sold shares of the company. Caxton Associates LP bought a new stake in shares of NextGen Healthcare in the 1st quarter valued at approximately $214,000. Acadian Asset Management LLC lifted its stake in shares of NextGen Healthcare by 3.1% during the 1st quarter. Acadian Asset Management LLC now owns 774,719 shares of the company’s stock worth $14,024,000 after acquiring an additional 23,625 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of NextGen Healthcare by 21.6% during the 1st quarter. JPMorgan Chase & Co. now owns 502,686 shares of the company’s stock worth $9,098,000 after acquiring an additional 89,388 shares during the last quarter. Martingale Asset Management L P lifted its stake in shares of NextGen Healthcare by 12.5% during the 1st quarter. Martingale Asset Management L P now owns 90,011 shares of the company’s stock worth $1,631,000 after acquiring an additional 10,013 shares during the last quarter. Finally, BNP Paribas Arbitrage SA lifted its stake in shares of NextGen Healthcare by 87.6% during the 1st quarter. BNP Paribas Arbitrage SA now owns 27,649 shares of the company’s stock worth $500,000 after acquiring an additional 12,912 shares during the last quarter. 74.11% of the stock is owned by institutional investors and hedge funds.
Shares of NASDAQ:NXGN opened at $14.76 on Friday. NextGen Healthcare has a 1-year low of $11.80 and a 1-year high of $23.80. The stock has a market cap of $992.85 million, a PE ratio of 73.80, a price-to-earnings-growth ratio of 2.73 and a beta of 1.15. The stock’s fifty day simple moving average is $15.71 and its two-hundred day simple moving average is $17.29.
About NextGen Healthcare
NextGen Healthcare, Inc engages in the development and marketing of electronic health records, practice management, revenue cycle management, and interoperability solutions. It offers the core; automation and workflow; analytics, population health, and patient engagement, interoperability; managed services; professional services; and client service and support.
Further Reading: What is the CBOE Russell 2000® Volatility Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.